Roche Diagnostics Australia › Health Topics › Women's Health
Roche Diagnostics is committed to women’s health at every stage of her life and to giving healthcare providers the confidence to safeguard the moments that matter most. Our innovative solutions in women’s health give physicians the ability to provide the right treatment at the right time, offering a confidence that only Roche Diagnostics can deliver. From cervical cancer screening to support in fertility, prenatal testing and pregnancy care to breast and ovarian cancer diagnosis to managing bone health, Roche Diagnostics is the trusted diagnostic partner that healthcare providers can depend on.
For the past 16 years, Eileen has strived to bridge the gap between laboratories and clinicians by educating healthcare professionals on new and innovative tests. When Eileen first joined Roche, her role was to support customers in creating greater awareness of the Harmony prenatal test. Her current role as Women's Health Disease Area Lead allows her to collaborate with leading women's health experts so that every Australian patient has access to Roche's highly innovative tests to ensure their best health outcome.
Conquering Cancer
Can you imagine a world with cervical cancer? Roche Diagnostics is a proud sponsor of the inspirational documentary - Conquering Cancer, Making History by Eliminating Cervical Cancer Everywhere - a film about incredible efforts made to eliminate cervical cancer for every woman and girl.
Pink & Blue for 22q
On the 22nd of November, 2021, the International 22q Awareness Day, Roche Diagnostics Australia joined the 22q Foundation Australia and New Zealand to help raise much-needed awareness for 22q. We challenged participants to choose an activity based on the colours pink or blue on 22nd November. We look forward to another successful event in 2022!
Webinar: The Use of Biomarkers in the Prediction, Prevention and Diagnosis of Preeclampsia
To support Pre-eclampsia Awareness Day in May, Roche collaborated with Prof Jon Hyett (RPA, Sydney) and Prof Shaun Brennecke (RWH, Melbourne) to conduct a webinar on “The Use of Biomarkers in the Prediction, Prevention and Diagnosis of Pre-eclampsia”. This event aimed to help further educate healthcare professionals on the clinical utility of biomarkers in pre-eclampsia.
This page is provided as a contact service and does not replace the advice of a physician. Roche cannot respond to questions about general medical information or questions regarding your personal medical condition. Medications and diagnostics products can not be directly ordered through this website. Please note that we do not respond to form letters or e-mail campaigns.
